Glucose monitoring specialist Dexcom expands its partnership with the OURA health tracking maker to supply STELO users and their wearer with metabolic health features, including meal visions and glucose data.
Stelo provides individuals 18 and over those who do not ask insulin to read the glucose around the clock, and provide personal visions in glucose health, providing users with canable information to make informed decisions. The correction helps in detecting natural, low or high glucose levels (blood defects).
Through partnership, Dexcom continuous glucose users, which received The FDA will be cleared in March last year, the meal and glucose.
Through the meal, the younger can take a picture of their foods through the OURA application, and food and nutrition analysis will be used to provide users with visions on how their meals or snacks affect the day. Meals focus on large food nutrients instead of calories. The goal is to better understand the Ura episode how their food affects their health.
The OURA application also provides users with recommendations on how to organize their meals “to avoid declining energy and intense desire.”
Glucose for the ring panels will provide graphs and contextual drawing to help them understand the relationship between meals, daily movement, glucose levels, tension and marks through the information collected through Stelo.
Users can also learn habits that will help them maintain or achieve optimal glucose levels, and reach “over the range”, which tracks when glucose levels are higher than the target range and provides an analysis of the AI ​​agreement for the glucose directions of the member.
Through partnership with Dexcom, users can buy Stelo CGM through OURA, Access and Glucose via the OURA application.
“Our product road map for this year is based on a strong investment in the AI-Forwards offers that enable the deepest understanding of the dynamic interaction of major health factors,” Holly Shelton, chief product employee in Ura, said in a statement.
“The addition of feeding features to experience our products was a subsequent natural step, especially given the extent to which the personal diet-and its effect on health.
The biggest direction
In November, Dexcom made Investment of $ 75 million in OURA and set up a strategic partnership to enable the dual -direction data between the CGM from Dexcom and the OURA ring.
A month later, Ora A closed A financing round from the series D 200 million, which amounts to the company’s evaluation of $ 5.2 billion.
In 2021, Ura scored 100 million dollars in the C. Series Tour after a year has passed, the company announced that it had reached a rating of $ 2.55 billion. OURA received $ 28 million in funding from Series B in 2020.
The company has acquired three companies in the past few years: the data company Sparta Science, Veri and Proxy DigitionD Intregateing Proxy.
In March, Ura She announced that she appointed her first medical official, Dr. Ricky Bloomfield. Before OURA, Bloomfield worked as a clinical and healthy informational leadership in Apple Health, with overseeing the launch of many features, including Apple health records on iPhone.